Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca starts late-stage study of key new cancer drug
Yahoo/Reuters
Thursday, May 8, 2014 - 10:54am
tags:
AstraZeneca, anti-PD-L1, MEDI4736, non-small cell lung cancer
Pfizer Raising AstraZeneca Bid Means More Job Cuts Needed
Bloomberg
Thursday, May 8, 2014 - 10:42am
tags:
Pfizer, AstraZeneca, layoffs, M&A
Cytomedix shutters R&D site after PhII failure
Fierce Biotech
Thursday, May 8, 2014 - 8:53am
tags:
Cytomedix, R&D
Teleflex plans layoffs, plant closures in response to 'cost pressures'
Mass Device
Thursday, May 8, 2014 - 8:51am
tags:
layoffs, Teleflex Medical, devices
Lundbeck to acquire Chelsea Therapeutics for up to $658 mln
Reuters
Thursday, May 8, 2014 - 8:33am
tags:
Lundbeck, Chelsea Therapeutics, M&A
Is Abbott Laboratories Headed for a Breakup?
Motley Fool
Thursday, May 8, 2014 - 8:32am
tags:
Abbott Labs, M&A, generics, Mylan Labs, Teva Pharmaceuticals
FDA approves GW drug trial
Yahoo/Investors Business Daily
Thursday, May 8, 2014 - 8:31am
tags:
FDA, GW Pharma, Epidiolex
Cytokinetics Still Has Value, Despite Setbacks
Seeking Alpha
Thursday, May 8, 2014 - 8:28am
tags:
Cytokinetics, Omecamtiv Mecarbil, Tirasemtiv
Allergan Reports Strong Q1 While Weighing Valeant Bid
Investors.com
Wednesday, May 7, 2014 - 6:37pm
tags:
Allergan, earnings, Valeant Pharmaceuticals
IPO Preview: Radius Health
Seeking Alpha
Wednesday, May 7, 2014 - 6:32pm
tags:
IPOs, Radius Health
Isis Pharma's Q1 Loss Widens
Yahoo/Zacks.com
Wednesday, May 7, 2014 - 6:31pm
tags:
Isis Pharmaceuticals, earnings
Pfizer And AstraZeneca: Innovation Will Not Follow Acquisition
Seeking Alpha
Wednesday, May 7, 2014 - 6:30pm
tags:
Pfizer, AstraZeneca, innovation, M&A
IPO Preview: Alder Biopharmaceuticals
Seeking Alpha
Wednesday, May 7, 2014 - 6:29pm
tags:
IPOs, Alder Biopharmaceuticals
10 big brands keep pumping out big bucks, with a little help from price hikes
Fierce Pharma Marketing
Wednesday, May 7, 2014 - 3:42pm
tags:
Xyrem, Jazz Pharmaceuticals, Humulin, Eli Lilly, Premarin, Mylan, Lunesta, Sunovion, Benicar, Daiichi Sankyo, Lantus, Sanofi, Viagra, Pfizer, Gleevec, Novartis, Copaxone, Teva Pharmaceuticals, EpiPen, drug pricing
The Biggest Biotech Catastrophes of the Week
Motley Fool
Wednesday, May 7, 2014 - 3:36pm
tags:
biotech, vintafolide, Endocyte, OncoGenex, custirsen, Athersys, MultiStem
1 Company Johnson & Johnson Should Buy
Motley Fool
Wednesday, May 7, 2014 - 3:33pm
tags:
JNJ, Pharmacyclics
3 Stocks Raising The Drugs Industry Higher
TheStreet.com
Wednesday, May 7, 2014 - 3:31pm
tags:
AbbVie, Teva Pharmaceuticals, JNJ
Genmab earnings boosted by Janssen collaboration
Yahoo/Reuters
Wednesday, May 7, 2014 - 3:30pm
tags:
Genmab, earnings, Janssen
Cell Therapeutics: Enticing To All, Convincing To None
Seeking Alpha
Wednesday, May 7, 2014 - 9:54am
tags:
Cell Therapeutics
What Should Merck Do With Its $14 Billion Windfall?
Motley Fool
Wednesday, May 7, 2014 - 9:51am
tags:
Merck, Bayer, restructuring

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.